Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
An osmotic tablet is an oral controlled-release dosage form that uses osmotic pressure to deliver medicine at a planned rate. It commonly contains an osmotically active core surrounded by a semipermeable membrane. Water enters through the membrane and creates pressure that pushes dissolved or suspended drug through a small delivery opening. The design can provide extended release over many hours.
read more about osmotic tablet ...Gastrointestinal fluid passes through the tablet's semipermeable outer membrane. The absorbed water dissolves drug or expands a push layer inside the tablet. Rising pressure moves the medication through a laser-drilled orifice at a controlled rate. Release is influenced by the formulation and membrane rather than relying only on tablet erosion.
Osmotic systems can produce relatively controlled drug delivery and reduce large fluctuations between peak and trough concentrations. Many products require less frequent dosing than immediate-release forms. Release can be less sensitive to gastrointestinal pH than some conventional formulations. Benefits depend on the individual medicine and do not mean every osmotic product performs identically.
The tablet is generally swallowed whole with liquid. Chewing, crushing, splitting, or dissolving it can damage the delivery system and release the dose improperly. Product-specific instructions determine whether food affects administration. Patients with severe gastrointestinal narrowing or swallowing difficulty require additional assessment because the shell does not deform like an ordinary tablet.
The nonabsorbable shell and insoluble components can pass through the digestive tract after the drug has been released. Patients can occasionally notice a tablet-like shell in the stool, which does not necessarily mean the dose failed. Damaged tablets, improper storage, or altered swallowing can change release. An osmotic tablet should not be substituted with another dosage form without checking dose and release characteristics.
No. Crushing can destroy the controlled-release mechanism and cause inappropriate drug release. The tablet should be swallowed whole unless its official instructions state otherwise.
The outer shell can remain intact after the medicine has been delivered. The empty or partly insoluble shell then passes through the digestive tract.
Not always. The drug is released from the system, but the nonabsorbable membrane or other insoluble parts can remain visible.
No. Extended-release medicines use many technologies, including matrices, coatings, beads, and osmotic systems. Handling instructions depend on the specific formulation.
Osmotic Pump Drug Delivery Systems?A Comprehensive Review. Pharmaceutics (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC9697821/. Date Accessed August 6, 2026.
CONCERTA (Methylphenidate Hydrochloride Extended-Release Tablets): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd. Date Accessed August 6, 2026.
INVEGA (Paliperidone Extended-Release Tablets): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916. Date Accessed August 6, 2026.
PROCARDIA XL (Nifedipine Extended-Release Tablets): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ebcb33c-f43b-4b36-9f94-9774b2a59e06. Date Accessed August 6, 2026.
GLUCOTROL XL (Glipizide Extended-Release Tablets): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eed99b60-d043-4249-9b2a-f05e46fb588d. Date Accessed August 6, 2026.